Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation

Oligomeric assembly of Amyloid-β (Aβ) is the main toxic species that contribute to early cognitive impairment in Alzheimer’s patients. Therefore, drugs that reduce the formation of Aβ oligomers could halt the disease progression. In this study, by using transgenic Caenorhabditis elegans model of Alz...

Full description

Bibliographic Details
Main Authors: Taweesak Tangrodchanapong, Prasert Sobhon, Krai Meemon
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.553579/full
_version_ 1818561901664141312
author Taweesak Tangrodchanapong
Prasert Sobhon
Krai Meemon
author_facet Taweesak Tangrodchanapong
Prasert Sobhon
Krai Meemon
author_sort Taweesak Tangrodchanapong
collection DOAJ
description Oligomeric assembly of Amyloid-β (Aβ) is the main toxic species that contribute to early cognitive impairment in Alzheimer’s patients. Therefore, drugs that reduce the formation of Aβ oligomers could halt the disease progression. In this study, by using transgenic Caenorhabditis elegans model of Alzheimer’s disease, we investigated the effects of frondoside A, a well-known sea cucumber Cucumaria frondosa saponin with anti-cancer activity, on Aβ aggregation and proteotoxicity. The results showed that frondoside A at a low concentration of 1 µM significantly delayed the worm paralysis caused by Aβ aggregation as compared with control group. In addition, the number of Aβ plaque deposits in transgenic worm tissues was significantly decreased. Frondoside A was more effective in these activities than ginsenoside-Rg3, a comparable ginseng saponin. Immunoblot analysis revealed that the level of small oligomers as well as various high molecular weights of Aβ species in the transgenic C. elegans were significantly reduced upon treatment with frondoside A, whereas the level of Aβ monomers was not altered. This suggested that frondoside A may primarily reduce the level of small oligomeric forms, the most toxic species of Aβ. Frondoside A also protected the worms from oxidative stress and rescued chemotaxis dysfunction in a transgenic strain whose neurons express Aβ. Taken together, these data suggested that low dose of frondoside A could protect against Aβ-induced toxicity by primarily suppressing the formation of Aβ oligomers. Thus, the molecular mechanism of how frondoside A exerts its anti-Aβ aggregation should be studied and elucidated in the future.
first_indexed 2024-12-14T00:56:46Z
format Article
id doaj.art-b8e6f9adcf194f3d927c5d67789ad4b7
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-14T00:56:46Z
publishDate 2020-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-b8e6f9adcf194f3d927c5d67789ad4b72022-12-21T23:23:31ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-09-011110.3389/fphar.2020.553579553579Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its FormationTaweesak TangrodchanapongPrasert SobhonKrai MeemonOligomeric assembly of Amyloid-β (Aβ) is the main toxic species that contribute to early cognitive impairment in Alzheimer’s patients. Therefore, drugs that reduce the formation of Aβ oligomers could halt the disease progression. In this study, by using transgenic Caenorhabditis elegans model of Alzheimer’s disease, we investigated the effects of frondoside A, a well-known sea cucumber Cucumaria frondosa saponin with anti-cancer activity, on Aβ aggregation and proteotoxicity. The results showed that frondoside A at a low concentration of 1 µM significantly delayed the worm paralysis caused by Aβ aggregation as compared with control group. In addition, the number of Aβ plaque deposits in transgenic worm tissues was significantly decreased. Frondoside A was more effective in these activities than ginsenoside-Rg3, a comparable ginseng saponin. Immunoblot analysis revealed that the level of small oligomers as well as various high molecular weights of Aβ species in the transgenic C. elegans were significantly reduced upon treatment with frondoside A, whereas the level of Aβ monomers was not altered. This suggested that frondoside A may primarily reduce the level of small oligomeric forms, the most toxic species of Aβ. Frondoside A also protected the worms from oxidative stress and rescued chemotaxis dysfunction in a transgenic strain whose neurons express Aβ. Taken together, these data suggested that low dose of frondoside A could protect against Aβ-induced toxicity by primarily suppressing the formation of Aβ oligomers. Thus, the molecular mechanism of how frondoside A exerts its anti-Aβ aggregation should be studied and elucidated in the future.https://www.frontiersin.org/article/10.3389/fphar.2020.553579/fullamyloid-βoligomersAlzheimer’s diseasefrondoside ACaenorhabditis elegans
spellingShingle Taweesak Tangrodchanapong
Prasert Sobhon
Krai Meemon
Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation
Frontiers in Pharmacology
amyloid-β
oligomers
Alzheimer’s disease
frondoside A
Caenorhabditis elegans
title Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation
title_full Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation
title_fullStr Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation
title_full_unstemmed Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation
title_short Frondoside A Attenuates Amyloid-β Proteotoxicity in Transgenic Caenorhabditis elegans by Suppressing Its Formation
title_sort frondoside a attenuates amyloid β proteotoxicity in transgenic caenorhabditis elegans by suppressing its formation
topic amyloid-β
oligomers
Alzheimer’s disease
frondoside A
Caenorhabditis elegans
url https://www.frontiersin.org/article/10.3389/fphar.2020.553579/full
work_keys_str_mv AT taweesaktangrodchanapong frondosideaattenuatesamyloidbproteotoxicityintransgeniccaenorhabditiselegansbysuppressingitsformation
AT prasertsobhon frondosideaattenuatesamyloidbproteotoxicityintransgeniccaenorhabditiselegansbysuppressingitsformation
AT kraimeemon frondosideaattenuatesamyloidbproteotoxicityintransgeniccaenorhabditiselegansbysuppressingitsformation